Insmed, Inc. (INSM)
124.03
-1.74
(-1.38%)
USD |
NASDAQ |
Aug 24, 16:00
124.03
0.00 (0.00%)
After-Hours: 19:58
Insmed Market Cap : 27.07B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 27.45B |
| August 20, 2026 | 27.30B |
| August 19, 2026 | 28.52B |
| August 18, 2026 | 28.04B |
| August 17, 2026 | 28.01B |
| August 14, 2026 | 27.01B |
| August 13, 2026 | 27.58B |
| August 12, 2026 | 28.87B |
| August 11, 2026 | 28.94B |
| August 10, 2026 | 29.41B |
| August 07, 2026 | 28.62B |
| August 06, 2026 | 28.93B |
| August 05, 2026 | 21.61B |
| August 04, 2026 | 21.56B |
| August 03, 2026 | 21.49B |
| July 31, 2026 | 21.35B |
| July 30, 2026 | 21.97B |
| July 29, 2026 | 22.33B |
| July 28, 2026 | 22.55B |
| July 27, 2026 | 22.68B |
| July 24, 2026 | 23.15B |
| July 23, 2026 | 23.26B |
| July 22, 2026 | 23.09B |
| July 21, 2026 | 23.52B |
| July 20, 2026 | 23.17B |
| Date | Value |
|---|---|
| July 17, 2026 | 23.45B |
| July 16, 2026 | 23.27B |
| July 15, 2026 | 23.78B |
| July 14, 2026 | 23.84B |
| July 13, 2026 | 23.63B |
| July 10, 2026 | 25.03B |
| July 09, 2026 | 25.61B |
| July 08, 2026 | 25.23B |
| July 07, 2026 | 24.43B |
| July 06, 2026 | 24.15B |
| July 02, 2026 | 24.16B |
| July 01, 2026 | 23.17B |
| June 30, 2026 | 23.09B |
| June 29, 2026 | 22.68B |
| June 26, 2026 | 22.38B |
| June 25, 2026 | 22.62B |
| June 24, 2026 | 22.40B |
| June 23, 2026 | 22.12B |
| June 22, 2026 | 21.35B |
| June 18, 2026 | 20.74B |
| June 17, 2026 | 21.32B |
| June 16, 2026 | 20.68B |
| June 15, 2026 | 21.10B |
| June 12, 2026 | 21.19B |
| June 11, 2026 | 20.94B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 31.57B |
| United Therapeutics Corp. | 21.89B |
| ACADIA Pharmaceuticals, Inc. | 5.100B |
| Biogen, Inc. | 32.21B |
| Gilead Sciences, Inc. | 182.13B |
Market Cap Related Metrics
| PS Ratio | 23.39 |
| Price to Book Value | 35.74 |
| Price | 124.03 |
| Earnings Yield | -3.31% |